Evidence map›Paper›PMID 27322431›Full record

ArticleOncotarget2016

Activation of volume-sensitive Cl- channel mediates autophagy-related cell death in myocardial ischaemia/reperfusion injury.

Yuesheng Xia, Yan Liu, Tong Xia, Xing Li, Cong Huo, Xin Jia, Lin Wang, Rong Xu, Ning Wang, Mingming Zhang and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yuesheng XiaDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yan LiuDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Tong XiaDepartment of Preventive Medicine, Sun Yat-sen University, Guangzhou, China.
Xing LiDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Cong HuoDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xin JiaDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Lin WangDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Rong XuDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Ning WangDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Mingming ZhangDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Hong LiDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xiaoming WangDepartment of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Air Force Medical University · CNXijing Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive reactive oxygen species (ROS) plays an important role in myocardial ischemia/reperfusion (I/R) injury, which triggers not only myocardial cellular apoptosis but also autophagy-related cell death, in which volume-sensitive outwardly rectifying (VSOR) Cl- channel-activated by ROS contributes to cell apoptotic volume decrease, playing an incipient incident of cellular apoptosis. However, whether VSOR Cl- channel concurrently participates in autophagy-related cell death regulation remains unclear. To illuminate the issue, studies underwent in myocardial vitro and vivo I/R model. Rats were performed to ischemia 30 minutes and subsequent reperfusion 24-96 hours, ROS scavenger (NAC), VSOR Cl- channel blocker (DCPIB) and autophagy inhibitor (3MA) were administered respectively. Results showed that oxidative stress, LC3-II stain and inflammation in myocardial tissue were markedly increased, lysosome associated membrane protein-2 (LAMP2) were significantly reduced with I/R group as compared with sham group, reperfusion significantly led to damage in myocardial tissue and heart function, whereas the disorder could be rescued through these agents. Moreover, primary neonatal rat cardiomyocytes hypoxia/reoxygenation model were administered, results showed that VSOR Cl- channel-activated by reoxygenation could cause both cell volume decrease and intracellular acidification, which further increased LC3 and depleted of LAMP2, resulting in autophagy-related cell death. Interestingly, VSOR Cl- channel-blocked by DCPIB could stably maintain the cell volume, intracellular pH, abundant LAMP2 and autophagic intensity regardless of ROS intension derived from reoxygenation injury or adding H2O2. These results first demonstrate that VSOR Cl- channel-activated is a pivotal event to trigger autophagy-related death, which reveals a novel therapeutic target to decrease myocardial I/R injury.

Indexed as

AutophagyAdenineAnimalsApoptosisCell ProliferationChloride ChannelsCytokinesHydrogen-Ion ConcentrationHypoxiaInflammationLysosomal-Associated Membrane Protein 2LysosomesMaleMicrotubule-Associated ProteinsMyocardial IschemiaMyocardium3-methyladenineAdenineAnxa3 protein, ratChloride ChannelsCytokinesLysosomal-Associated Membrane Protein 2Microtubule-Associated ProteinsReactive Oxygen Speciesautophagycell deathischemia/reperfusion injuryPathology Sectionreactive oxygen speciesVSOR Cl- channel

Identifiers

PMID27322431
PMCPMC5129937
OpenAlexW2421898246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.